CpG寡核苷酸经Toll样受体9和脾酪氨酸激酶通路诱导小鼠急性血小板减少
在BALB/c小鼠中测试两种CpG寡核苷酸(ODN 2395和ISIS 120704)诱导血小板减少的能力及机制;两者分别于3小时和24小时内诱导急性剂量依赖性血小板减少,IVIg、Syk抑制剂或TLR9拮抗剂均可显著挽救,体外实验提示IVIg和Syk依赖的血小板清除通路起主要作用。
要点
- ODN 2395和ISIS 120704分别于3小时和24小时内诱导小鼠急性剂量依赖性血小板减少。
- IVIg、Syk抑制剂或TLR9拮抗剂均可显著挽救CpG寡核苷酸诱导的血小板减少。
- 体外CpG寡核苷酸可激活人血小板,与THP-1单核细胞增强的IVIg和Syk依赖吞噬作用显著相关。
核心结论
- 结果提示CpG寡核苷酸诱导急性炎症相关(IVIg敏感)血小板减少,Syk或TLR9阻断可减轻。
- IVIg和Syk依赖的血小板清除通路似乎主要导致该血小板减少。
研究设计与样本
- BALB/c小鼠先采血,再注射滴定剂量的CpG寡核苷酸并测定血小板计数。
- 小鼠接受静脉注射免疫球蛋白(IVIg)或Toll样受体9(TLR9)和脾酪氨酸激酶(Syk)的各种抑制剂和拮抗剂以确定其对血小板减少的影响。
- 体外实验检测CpG寡核苷酸对人血小板的激活及THP-1单核细胞的吞噬作用。
主要发现
- 与生理盐水处理小鼠或2'-O-甲氧乙基修饰的反义ODN处理小鼠相比,ODN 2395和ISIS 120704分别在3小时和24小时内诱导急性剂量依赖性血小板减少。
- 血小板减少与血浆单核细胞趋化蛋白1显著增加相关。
- IVIg给药显著挽救CpG寡核苷酸诱导的血小板减少,Syk抑制剂或TLR9拮抗剂治疗同样显著挽救。
- 体外CpG寡核苷酸可激活人血小板,且与THP-1单核细胞增强的IVIg和Syk依赖吞噬作用显著相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CpG oligonucleotides (ODNs) are synthetic single-stranded DNA sequences that act as immunostimulants. They have been increasingly used to treat several cancers; however, thrombocytopenia is a potential recognized side effect of some sequences. OBJECTIVES: We tested the ability of 2 CpG ODNs (ODN 2395 and ISIS 120704) to induce thrombocytopenia when administered to BALB/c mice and determined mechanisms associated with thrombocytopenia. METHODS: BALB/c mice were prebled and then injected with titrated doses of CpG ODNs, and platelet counts were determined. The mice were treated with intravenous immunoglobulin (IVIg) or various inhibitors and antagonists of toll-like receptor 9 (TLR9) and spleen tyrosine kinase (Syk) to determine their effects on thrombocytopenia. RESULTS: Compared with saline-treated mice or mice treated with 2'-O-methoxyethyl-modified antisense ODN, both ODN 2395 and ISIS 120704 induced acute dose-dependent thrombocytopenia within 3 and 24 hours, respectively. The thrombocytopenia was associated with significant increases in plasma monocyte chemoattractant protein 1. IVIg administration significantly rescued the CpG ODN-induced thrombocytopenia, as did treatment with either a Syk inhibitor or TLR9 antagonists. In vitro, CpG ODN could activate human platelets and this correlated significantly with enhanced IVIg- and Syk-dependent phagocytosis by THP-1 monocytes. CONCLUSION: These results suggest that CpG ODNs induce acute inflammatory-associated (IVIg-sensitive) thrombocytopenia that can be alleviated by Syk- or TLR9-blockade, and an IVIg- and Syk-dependent platelet clearance pathway appears primarily responsible for the thrombocytopenia.
引用
- Johansson K, Maouia A, Rebetz J, et al. CpG oligonucleotides induce acute murine thrombocytopenia dependent on toll-like receptor 9 and spleen tyrosine kinase pathways. J Thromb Haemost. 2024. PMID: 39155024. doi:10.1016/j.jtha.2024.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。